Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

ClinicalTrials.gov ID: NCT05899608

Public ClinicalTrials.gov record NCT05899608. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Multiregional Phase 3 Study of Ivonescimab Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung Cancer (HARMONi-3)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3 Randomized, double-blind, Multiregional Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung Cancer. The primary endpoint is overall survival and progression free survival assessed by investigator. The key secondary endpoints include response and safety.

Study identification

NCT ID
NCT05899608
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Summit Therapeutics
Industry
Enrollment
1,600 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 26, 2023 (Actual)
Primary completion
Dec 31, 2028 (Estimated)
Completion
Dec 31, 2029 (Estimated)
Last update posted
Oct 8, 2026

2023 – 2029

United States locations

U.S. sites
76
U.S. states
28
U.S. cities
64
Facility City State ZIP Site status
Banner University Medical Center Phoenix Arizona 85006 —
TMC Healthcare Tucson Arizona 85711 —
Genesis Cancer and Blood Institute Hot Springs Arkansas 71913 —
University of Arkansas Little Rock Arkansas 72205 —
LA Cancer Network Anaheim California 92801 —
The Oncology Institute of Hope & Innovation Cerritos California 90703 —
University of Southern California (USC) Los Angeles California 90033 —
Cedar Sinai Medical Center Los Angeles California 90048 —
Valkyrie Clinical Trials Los Angeles California 90067 —
Sutter Institute for Medical Research Sacramento California 95816 —
UC Davis Medical Center Sacramento California 95817 —
University of California Los Angeles (UCLA) Santa Monica California 90404 —
Providence Medical Foundation Santa Rosa California 95403 —
Kaiser Permanente Vallejo California 94589 —
Rocky Mountain Cancer Lone Tree Colorado 80124 —
Banner MD Anderson Cancer Center at North Colorado Medical Center Loveland Colorado 80538 —
Hartford Hospital Hartford Connecticut 06053 —
Yale University New Haven Connecticut 06510 —
Florida Cancer Specialists & Research Institute (FCS)-East Fort Myers Florida 33901 —
BioResearch Partner- Hialeah Hospital Hialeah Florida 33013 —
Memorial Healthcare System Hollywood Florida 33021 —
Mayo Clinic Jacksonville Florida 32224 —
Cancer Specialists of North Florida Jacksonville Florida 32256 —
Ocala Oncology Ocala Florida 34474 —
Cancer Care of Brevard Palm Bay Florida 32901 —
Ascension Sacred Heart Health System Pensacola Florida 32504 —
Exigent Network Petersburg Florida 33709 —
BRCR Medical Center Inc Plantation Florida 33322 —
Florida Cancer Specialists & Research Institute (FCS) - North St. Petersburg Florida 33705 —
BRCR Medical Center Inc. Tamarac Florida 33321 —
Florida Cancer Specialists & Research Institute (FCS)-South West Palm Beach Florida 33401 —
Central Georgia Cancer Care Macon Georgia 31210 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
Illinois Cancer Care P.C. Peoria Illinois 61615 —
University of Kansas Cancer Center Westwood Kansas 66205 —
Baptist Health Lexington Kentucky 40503 —
Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21187 —
Ascension Saint Agnes Hospital Baltimore Maryland 21229 —
Lahey Hospital Burlington Massachusetts 01805 —
University of Michigan Ann Arbor Michigan 48109 —
Trinity Health Ann Arbor Michigan 48197 —
Karmanos Cancer Insitute Detroit Michigan 48201 —
Henry Ford Hospital Detroit Michigan 48202 —
Mayo Clinic Rochester Minnesota 55905 —
Park Nicollet Institute Saint Paul Minnesota 55101 —
American Oncology Partners, PA Kansas City Missouri 64132 —
Washington University St.Louis St Louis Missouri 63110 —
St. Vincent Cancer Center Billings Montana 59102 —
University of Nebraska Medical Center (UNMC) Omaha Nebraska 68105 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
Mount Sinai New York New York 10029 —
Memorial Sloan Kettering New York New York 10065 —
SUNY Upstate Medical University Syracuse New York 13210 —
University of North Carolina Chapel Hill North Carolina 27514 —
Levine Center Charlotte North Carolina 28204 —
Oncology Hematology Care (OHC), Inc Cincinnati Ohio 45242 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
Cleveland Clinic Cleveland Ohio 44195 —
Willamette Valley Cancer Institute and Research Center (WVCI) Eugene Oregon 97401 —
Medical University of South Carolina (MUSC) Charleston South Carolina 29425 —
Prisma Health-Upstate Greenville South Carolina 29605 —
West Cancer Center Memphis Tennessee 38138 —
SCRI-Nashville Nashville Tennessee 37203 —
Texas Oncology- Austin Austin Texas 78745 —
Texas Oncology-Dallas Dallas Texas 75246 —
UT Southwestern Medical Center Dallas Texas 75390 —
Houston Methodist Hospital Houston Texas 77030 —
MD Anderson Cancer Center Houston Texas 77030 —
Texas Oncology-San Antonio San Antonio Texas 78216 —
Texas Oncology-Tyler Tyler Texas 75702 —
University of Texas at Tyler Tyler Texas 75708 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Virginia Cancer Reston Virginia 20190 —
Swedish Cancer Institute Seattle Washington 98103 —
Cancer Care NW Centers Spokane Washington 99202 —
Carbone Cancer Center Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 184 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05899608, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05899608 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →